Category Specific RSS

Categories: News

International payments processor Novatti grows revenue by 45%

Fintech developer and transactions processor Novatti (ASX: NOV) has reported record payment processing revenues for the quarter ending December 31, 2019, a rise of 45% compared to the corresponding 2018 quarter.

The increase from $1.15m to $1.55m comes solely from Novatti’s international transaction processing business, just one division of the Company which has a banking licence application pending and expected to be granted in early 2020. 

“Growing Novatti’s core transaction processing business remains a key focus for our team and we expect strong revenue growth to continue here in FY20,” said Novatti CEO, Peter Cook. 

“From a strategic point of view, this is welcomed, as we believe many of Novatti’s existing transaction processing customers will be primary customers for future banking services, aiding broader growth for the company.”

The significant growth in their payment processing business continues a strong 6 months for Novatti which last week reported that strategic investors had committed $18m in their banking service subsidiary, enabling the Novatti to meet the Tier 1 capital requirements for the licence and working capital without any further funding required. 

Upon granting of the licence, Novatti intends to launch a digital banking service which will target migrant populations and leverage existing fintech infrastructure Novatti has developed. 

With its growth in payment processing revenue, the Company has reported consecutive cash flow positive quarters in Q419 and Q120. Novatti is expected to release Q220 figures next week. 

Novatti invites investors to keep up to date with company news, events and industry research by joining the Novatti mailing list at: https://www.novattigroup.com/subscribe


*Owners of this website are shareholders in a company mentioned in this article and have been engaged by them to assist in investor communications

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US

Atomo Diagnostics (ASX:AT1) has secured a significant new order for its patented Pascal cassette, with…

1 week ago

June 2025 quarter CPI no roadblock to August RBA rate cut

The June 2025 quarter CPI data released today were cheered by mortgage holders and share…

2 weeks ago

Vection Secures $7.3M Defence Extension as AI Demand Strengthens

AI Gains Ground in Defence Sector As governments increase investment in defence technology, AI-powered tools…

3 weeks ago

Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology

Calix Limited (ASX:CXL) has taken a significant leap forward in developing Australia’s low-emissions steel value…

3 weeks ago

Harris Technology boosts retail margins in FY25 through growth of refurbished tech

Online tech retailer Harris Technology (ASX: HT8) has delivered a strong lift in gross product…

4 weeks ago

Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.

In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics…

1 month ago